Aniling – accelerating epigenomics

Company. We are committed to bring advances in the Genomics arena to everyday’s health care and disease prevention.

Technology. Our technology solves DNA sequencing critical limitations allowing simultaneous genome and epigenome analysis.

Products: Aniling products are based on GEUS technology and provide a bolt-on workflow from library preparation to clinical report.

About Us

GEUS Technology

Aniling owns the GEUS technology, which unifies genetic and epigenetic sequencing and provides end-to-end solutions for the right treatment decisions in oncology. Based on GEUS, Aniling is developing a set of products for cancer diagnostic.

GEUS-CLL

The first Aniling product is the most comprehensive Chronic Lymphocytic Leukemia Next Generation Sequencing diagnostics panel. The GEUS-CLL delivers accurate staging and treatment decisions. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.

Latest News

News

Aniling obtains European certification for diagnostic tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy

Aniling has obtained CE certification for its first in vitro diagnostic (IVD) tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. Aniling has successfully complied with the requirements established …

News

Open Position: Quality Assurance and Regulatory Affairs (QA/RA) Manager [Aniling202206QM]

Aniling is looking for a motivated QA/RA Manager to maintain and improve our company-wide quality management system that complies with the requirements of ISO 13485 and the regulation under which …

Read Our Blog

for precision medicine | against cancer | technology innovation